Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorWILLEMSE, S.
dc.contributor.authorSMIT, C.
dc.contributor.authorSOGNI, P.
dc.contributor.authorSARCLETTI, M.
dc.contributor.authorUBERTI-FOPPA, C.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorWITTKOP, Linda
dc.contributor.authorRABEN, D.
dc.contributor.authorD'ARMINIO MONFORTE, A.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorDABIS, Francois
dc.contributor.authorVAN DER VALK, M.
dc.date.accessioned2020-07-20T11:54:30Z
dc.date.available2020-07-20T11:54:30Z
dc.date.issued2019-10
dc.identifier.issn1365-2893 (Electronic) 1352-0504 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/10528
dc.description.abstractEnThe incidence of hepatocellular carcinoma (HCC) in patients co-infected with HIV and hepatitis B virus (HBV) or hepatitis C virus (HCV) is increasing. In patients with cirrhosis, guidelines recommend HCC screening every 6 months. We assessed compliance with HCC screening guidelines in cirrhotic HBV/HCV-HIV-co-infected patients. HBV/HCV-HIV-co-infected patients with cirrhosis were enrolled from 4 European prospective cohorts participating in the COHERE collaboration, followed from 1 January 2005-1 January 2015. Assessment of liver cirrhosis was based on clinical diagnosis and liver biopsy or Fibroscan. Compliance with HCC screening guidelines was defined as one ultrasound every 6 months. Generalized estimating equation models adjusted for repeated measurements were fitted to determine predictors of low compliance. Different sensitivity analyses were performed and validation of the data was carried out by randomly checking 10% of each cohort's data. 646 HIV-patients with the diagnosis of cirrhosis were included: 518 (80%) HCV-, 85 (13%) HBV- and 43 (7%) HBV/HCV-co-infected. Median age at cirrhosis diagnosis was 44 years, median follow-up time since diagnosis was 5.3 years. Screening </=6 months was performed in 6-18% of individuals from 2005-2015. If the screening interval was increased to 9 or 12 months, compliance improved to 7-24% and 7-30% respectively. Thus, compliance with HCC screening guidelines in cirrhotic HIV-patients co-infected with HBV and/or HCV in Europe is low. In light of an ageing population and the increasing prevalence of liver cirrhosis this situation needs to be addressed urgently. This article is protected by copyright. All rights reserved.
dc.language.isoENen_US
dc.subject.enMORPH3Eus
dc.subject.enColl_EuroCoord
dc.subject.enColl_COHERE
dc.title.enLow compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co-infected HIV patients with cirrhosis
dc.title.alternativeJ Viral Hepaten_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1111/jvh.13146en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed31136059en_US
bordeaux.journalJournal of Viral Hepatitisen_US
bordeaux.page1224-1228en_US
bordeaux.volume26en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.issue10en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03162540
hal.version1
hal.date.transferred2021-03-08T14:20:50Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft.jtitle=Journal%20of%20Viral%20Hepatitis&amp;rft.date=2019-10&amp;rft.volume=26&amp;rft.issue=10&amp;rft.spage=1224-1228&amp;rft.epage=1224-1228&amp;rft.eissn=1365-2893%20(Electronic)%201352-0504%20(Linking)&amp;rft.issn=1365-2893%20(Electronic)%201352-0504%20(Linking)&amp;rft.au=WILLEMSE,%20S.&amp;SMIT,%20C.&amp;SOGNI,%20P.&amp;SARCLETTI,%20M.&amp;UBERTI-FOPPA,%20C.&amp;rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée